| Product Code: ETC7539725 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chemotherapy-Induced Peripheral Neuropathy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F |
3.3 India Chemotherapy-Induced Peripheral Neuropathy Market - Industry Life Cycle |
3.4 India Chemotherapy-Induced Peripheral Neuropathy Market - Porter's Five Forces |
3.5 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Chemotherapy-Induced Peripheral Neuropathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India leading to higher chemotherapy usage |
4.2.2 Growing awareness about the side effects of chemotherapy-induced peripheral neuropathy among healthcare professionals and patients |
4.2.3 Technological advancements in the treatment and management of chemotherapy-induced peripheral neuropathy |
4.3 Market Restraints |
4.3.1 High cost associated with the treatment of chemotherapy-induced peripheral neuropathy |
4.3.2 Limited access to specialized healthcare facilities for the management of peripheral neuropathy in India |
5 India Chemotherapy-Induced Peripheral Neuropathy Market Trends |
6 India Chemotherapy-Induced Peripheral Neuropathy Market, By Types |
6.1 India Chemotherapy-Induced Peripheral Neuropathy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.4 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.5 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure, 2021- 2031F |
6.1.6 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Narcotics, 2021- 2031F |
6.2 India Chemotherapy-Induced Peripheral Neuropathy Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.3 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.4 India Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Chemotherapy-Induced Peripheral Neuropathy Market Import-Export Trade Statistics |
7.1 India Chemotherapy-Induced Peripheral Neuropathy Market Export to Major Countries |
7.2 India Chemotherapy-Induced Peripheral Neuropathy Market Imports from Major Countries |
8 India Chemotherapy-Induced Peripheral Neuropathy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on chemotherapy-induced peripheral neuropathy in India |
8.2 Adoption rate of new treatment modalities for chemotherapy-induced peripheral neuropathy |
8.3 Patient satisfaction scores related to the management of chemotherapy-induced peripheral neuropathy |
8.4 Rate of adverse events reported due to chemotherapy-induced peripheral neuropathy treatments |
8.5 Number of healthcare professionals trained in the diagnosis and management of chemotherapy-induced peripheral neuropathy |
9 India Chemotherapy-Induced Peripheral Neuropathy Market - Opportunity Assessment |
9.1 India Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Chemotherapy-Induced Peripheral Neuropathy Market - Competitive Landscape |
10.1 India Chemotherapy-Induced Peripheral Neuropathy Market Revenue Share, By Companies, 2024 |
10.2 India Chemotherapy-Induced Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here